Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Deglutition Disorders, Head and Neck Neoplasms, Radiation Injuries, Salivary Gland Neoplasms, Xerostomia, Mucositis

NCT00095927 2017-01-04

Randomized Amifostine For SCCHN

Phase 2 Completed

58 enrolled

Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Radiation Injuries, Xerostomia, Mucositis

NCT00698204 2014-06-05

Cox-2 Inhibition in Radiation-induced Oral Mucositis

Phase 2 Completed

43 enrolled 10 charts

Head & NeckOther

Head and Neck Neoplasms, Stomatitis, Mucositis

NCT01247246 2014-05-26

Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer

Phase 2 Unknown

160 enrolled

GastrointestinalHead & NeckOther

Digestive System Diseases, Gastroenteritis, Gastrointestinal Diseases, Head and Neck Neoplasms, Stomatognathic Diseases, Mouth Diseases, Neoplasms, Neoplasms by Site, Stomatitis, Mucositis

NCT00230191 2007-01-15

Safety and Efficacy of RK0202 in Oral Mucositis

Phase 2 Completed

110 enrolled

Head & NeckOther

Head and Neck Neoplasms, Mouth Diseases, Stomatitis, Oral Ulcer, Mucositis

Clinical Trials

KEVLARx

PREVLAR

TK112690

Phase 2a Study to Evaluate Suppression of Radiotherapy-induced Mucositis by TK112690

Kanglaite Reduce the Toxicity of Radiotherapy of Head and Neck Cancer Phase II Study

ESMULLLAT

Randomized Study of Beet Root in Locally Advanced Squamous Cell Cancer of the Head and Neck

Brilacidin

Analgesic Effects of Topical Ketamine Mouthwash in Patients Receiving Chemoradiation or Radiotherapy for Head & Neck Cancer

Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer

Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia

Randomized Amifostine For SCCHN

Cox-2 Inhibition in Radiation-induced Oral Mucositis

Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer

Safety and Efficacy of RK0202 in Oral Mucositis